Medprin Regenerative Medical Technologies Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Medprin Regenerative Medical Technologies Co., Ltd.

Why is Medprin Regenerative Medical Technologies Co., Ltd. ?

Flat results in Mar 26

OPERATING PROFIT(Q) Lowest at CNY 21.57 MM
OPERATING PROFIT MARGIN(Q) Lowest at 27.52 %
PRE-TAX PROFIT(Q) Lowest at CNY 23.53 MM

With ROE of 13.27%, it has a expensive valuation with a 0.83 Price to Book Value

Over the past year, while the stock has generated a return of -21.77%, its profits have risen by 22.7% ; the PEG ratio of the company is 0.3
At the current price, the company has a high dividend yield of 1.5

Below par performance in long term as well as near term

Along with generating -21.77% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Medprin Regenerative Medical Technologies Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Medprin Regenerative Medical Technologies Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Medprin Regenerative Medical Technologies Co., Ltd.

-21.77%

0.30

48.89%

China Shanghai Composite

16.78%

1.20

13.96%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

23.89%

EBIT Growth (5y)

47.20%

EBIT to Interest (avg)

35.56

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.26

Sales to Capital Employed (avg)

0.41

Tax Ratio

14.29%

Dividend Payout Ratio

41.34%

Pledged Shares

Institutional Holding

ROCE (avg)

9.56%

ROE (avg)

8.17%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.83

EV to EBIT

3.54

EV to EBITDA

2.96

EV to Capital Employed

0.73

EV to Sales

1.02

PEG Ratio

0.28

Dividend Yield

1.53%

ROCE (Latest)

20.66%

ROE (Latest)

13.27%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

NET SALES(HY)

At CNY 197.97 MM has Grown at 23.92%

RAW MATERIAL COST(Y)

Fallen by -8.03% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -35.61 %

-5What is not working for the Company

OPERATING PROFIT(Q)

Lowest at CNY 21.57 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 27.52 %

PRE-TAX PROFIT(Q)

Lowest at CNY 23.53 MM

NET PROFIT(Q)

Lowest at CNY 20.51 MM

EPS(Q)

Lowest at CNY 0.31

Here's what is working for Medprin Regenerative Medical Technologies Co., Ltd.

Net Sales

At CNY 197.97 MM has Grown at 23.92%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Debt-Equity Ratio

Lowest at -35.61 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -8.03% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Medprin Regenerative Medical Technologies Co., Ltd.

Operating Profit

Lowest at CNY 21.57 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 27.52 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY 23.53 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY 20.51 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY 0.31

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)